BY 2050, 115 MILLION PEOPLE WILL SUFFER
FROM NEURODEGENERATIVE DISEASES.
NO EFFECTIVE TREATMENT EXISTS TODAY.

NEUROPLAST AIMS TO GIVE BACK TREATMENT
PERSPECTIVE TO MILLIONS OF PEOPLE WITH A
FIRST-IN-KIND STEM CELL THERAPY TO COMBAT NEURODEGENERATIVE DISEASES.